Sectoral Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Sectoral Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$706K	Sell	10,111 -740	-7%	-$54.1K	0.49%	50
2026 Q1	$821K	Sell	10,851 -2,634	-20%	-$150K	0.68%	38
2025 Q4	$570K	Buy	+13,485	New	+$755K	0.46%	60
2020 Q3	–	Sell	-1,780	Closed	-$618K	–	151
2020 Q2	$618K	Buy	+1,780	New	+$555K	0.06%	121
2018 Q4	–	Sell	-5,484	Closed	-$5.01M	–	125
2018 Q3	$5.01M	Buy	5,484 +576	+12%	+$492K	0.53%	53
2018 Q2	$3.6M	Sell	4,908 -1,686	-26%	-$1.94M	0.4%	58
2018 Q1	$10.5M	Sell	6,594 -1,260	-16%	-$1.62M	1.15%	32
2017 Q4	$7.04M	Buy	+7,854	New	+$4.65M	0.88%	33
2016 Q2	–	Sell	-851	Closed	-$175K	–	72
2016 Q1	$175K	Sell	851 -8,291	-91%	-$1.59M	0.01%	80
2015 Q4	$2.31M	Buy	9,142 +2,182	+31%	+$449K	0.1%	60
2015 Q3	$1.14M	Buy	6,960 +303	+5%	+$53.6K	0.05%	70
2015 Q2	$1.25M	Buy	6,657 +1,383	+26%	+$238K	0.05%	67
2015 Q1	$870K	Buy	+5,274	New	+$1.08M	0.03%	74

Other funds holding NKTR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sectoral Asset Management's NKTR Position: Q2 2026 in Review

Sectoral Asset Management reduced its Nektar Therapeutics (NKTR) stake by 6.8% in Q2 2026, selling an estimated $54.1K and leaving 10,111 shares worth $706K. The position accounts for 0.49% of the portfolio, ranked #50.

Sectoral Asset Management first reported a position in NKTR in Q1 2015 and has held it in 13 quarters since. The position peaked at $10.5M in Q1 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

Sectoral Asset Management held 10,111 shares of Nektar Therapeutics worth $706K as of Q2 2026.
Sectoral Asset Management sold 740 Nektar Therapeutics shares in Q2 2026, an estimated $54.1K.
Nektar Therapeutics made up 0.49% of Sectoral Asset Management's portfolio in Q2 2026, its #50 holding.
Sectoral Asset Management first reported a position in Nektar Therapeutics in Q1 2015 and has held it in 13 quarters since.
Sectoral Asset Management's Nektar Therapeutics position peaked at $10.5M in Q1 2018.
240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.